Insider · CIK 0001557350
Gregory A Woods
Files at ALOT (AstroNova, Inc.). First filing -, latest -.
In brief
Gregory A Woods files SEC Form 4 as CEO and director at ALOT (AstroNova, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregory A Woods has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +4,654 | $0.00 | $0 | 210,610 | Jun 12, 2025 |
| Jun 10, 2025 | ALOT AstroNova, Inc. | FTax withholding Common Stock | -1,371 | $9.01 | $12k | 209,239 | Jun 12, 2025 |
| Jun 10, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -4,654 | $0.00 | $0 | 9,310 | Jun 12, 2025 |
| Apr 2, 2025 | ALOT AstroNova, Inc. | AGrant or award Common Stock | +352 | $7.81 | $2,752 | 205,956 | Apr 24, 2025 |
| Apr 17, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +1,969 | $0.00 | $0 | 202,549 | Apr 21, 2025 |
| Apr 17, 2025 | ALOT AstroNova, Inc. | FTax withholding Common Stock | -580 | $8.10 | $4,698 | 201,969 | Apr 21, 2025 |
| Apr 18, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +5,151 | $0.00 | $0 | 207,120 | Apr 21, 2025 |
| Apr 18, 2025 | ALOT AstroNova, Inc. | FTax withholding Common Stock | -1,517 | $8.10 | $12k | 205,603 | Apr 21, 2025 |
| Apr 17, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,969 | $0.00 | $0 | 1,969 | Apr 21, 2025 |
| Apr 18, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -5,151 | $0.00 | $0 | 0 | Apr 21, 2025 |
| Apr 14, 2025 | ALOT AstroNova, Inc. | AGrant or award Restricted Stock Unitsderivative | +29,444 | $0.00 | $0 | 29,444 | Apr 16, 2025 |
| Apr 7, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +7,934 | $0.00 | $0 | 202,604 | Apr 9, 2025 |
| Apr 7, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +443 | $0.00 | $0 | 203,047 | Apr 9, 2025 |
| Apr 7, 2025 | ALOT AstroNova, Inc. | FTax withholding Common Stock | -2,467 | $8.98 | $22k | 200,580 | Apr 9, 2025 |
| Apr 7, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,934 | $0.00 | $0 | 0 | Apr 9, 2025 |
| Apr 7, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -443 | $0.00 | $0 | 885 | Apr 9, 2025 |
| Mar 21, 2025 | ALOT AstroNova, Inc. | MOption exercise Common Stock | +6,133 | $0.00 | $0 | 196,489 | Mar 25, 2025 |
| Mar 21, 2025 | ALOT AstroNova, Inc. | FTax withholding Common Stock | -1,819 | $9.87 | $18k | 194,670 | Mar 25, 2025 |
| Mar 21, 2025 | ALOT AstroNova, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,133 | $0.00 | $0 | 6,133 | Mar 25, 2025 |
| Jan 29, 2025 | ALOT AstroNova, Inc. | AGrant or award Common Stock | +314 | $10.21 | $3,205 | 190,356 | Jan 30, 2025 |
Questions about Gregory A Woods
Answered from the filings on this page, as of the latest one.
Is Gregory A Woods buying or selling?
Gregory A Woods has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregory A Woods's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory A Woods has 0.
Where does Gregory A Woods file Form 4?
Gregory A Woods has filed Form 4 at ALOT (AstroNova, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.